Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9510)	4/2/1999 9:49:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Perhaps but doubt they will list XOMA.

To: Bluegreen who wrote (9510)	4/2/1999 11:01:00 PM
From: aknahow	Read Replies (2) \| Respond to of 17367

Competition? United States Patent 5,877,151 Pereira March 2, 1999 Method for inhibiting production of tumor necrosis factor Abstract The present invention contemplates a composition and method for treating septic shock in a mammal or as a prophylactic treatment prior to a surgical procedure, comprising administering a therapeutically effective amount of a bacterial lipopolysaccharide binding peptide derived from CAP37 protein. In a preferred version, the composition and method of use may comprise a peptide comprising amino acids 20-44 or 120-146 of CAP37 or subunits thereof. Inventors: Pereira; Heloise Anne (Edmond, OK) Assignee: The Board of Regents of the University of Oklahoma () Appl. No.: 840519 Filed: April 21, 1997 U.S. Class: 514/12; 514/13; 530/324; 530/326 Intern'l Class: C07K 007/06; C07K 014/52; C07K 014/435 Field of Search: 514/12,13 530/324,326